The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial
暂无分享，去创建一个
P. Kaiser | A. Joussen | S. Wolf | U. Buetehorn | D. Boyer | B. Stemper | M. Boettger | T. Zimmermann | R. Sandbrink | J. Hoechel | O. Zeitz | T. Schmelter | Gesa Deeg | Annett Richter | Ulf Buetehorn | Walter Schmitt